Featured News

 

Latest News

BioInvent International AB Upgrades its Manufacturing Facility
BioInvent International AB Upgrades its Manufacturing Facility
News   Apr 26, 2017

BioInvent INernational AB expands its manufacturing capability with 3, 50, 200 and 1000 liter bioreactors from Merck.

READ MORE

Propath Receives Queen’s Award for Enterprise
Propath Receives Queen’s Award for Enterprise
News   Apr 26, 2017

Award for international trade recognises outstanding, world-class drug development services.

READ MORE

Enamine, EMBL Partner on Cancer Drug Discovery Research
Enamine, EMBL Partner on Cancer Drug Discovery Research
News   Apr 25, 2017

A strategic agreement between Europe’s flagship laboratory for basic research in molecular biology and the world’s largest medicinal chemistry design house.

READ MORE

Reversing Gene Damage to Treat Blindness
Reversing Gene Damage to Treat Blindness
News   Apr 24, 2017

n mouse models, advanced gene editing tool reprogrammed photoreceptor rods to mutation-resistant cones.

READ MORE

Malaria Parasite Protein Shows Promise as Cancer Therapeutic
Malaria Parasite Protein Shows Promise as Cancer Therapeutic
News   Apr 21, 2017

A drug created from a malaria protein stopped tumour growth of chemotherapy-resistant bladder cancer, offering hope for cancer patients not responding to standard treatments.

READ MORE

How Cancer Evades the Immune System
How Cancer Evades the Immune System
News   Apr 21, 2017

A team of scientists from Singapore has discovered new ways in which cancers can escape the body’s immune system.

READ MORE

Synpromics Raise £5.2m in its Latest Fundraising Round
Synpromics Raise £5.2m in its Latest Fundraising Round
News   Apr 20, 2017

Synpromics, a leading synthetic promoter and gene control company has raised £5.2m in its latest funding round.

READ MORE

Agilent Technologies Presents Thought Leader Award to Professor Dwight Stoll for Separation Science Research
Agilent Technologies Presents Thought Leader Award to Professor Dwight Stoll for Separation Science Research
News   Apr 20, 2017

Prof. Stoll receives the award in support of his research, applying two-dimensional liquid chromatography (2D-LC) to biopharmaceutical analysis.

READ MORE

FDA Approves Pembrolizumab for Hodgkin Lymphoma
FDA Approves Pembrolizumab for Hodgkin Lymphoma
News   Apr 20, 2017

On March 14, the Food and Drug Administration (FDA) approved pembrolizumab (Keytruda®) for the treatment of some patients with classical Hodgkin lymphoma (cHL).

READ MORE

The Next Generation of Pancreatic Cancer Therapeutics
The Next Generation of Pancreatic Cancer Therapeutics
News   Apr 20, 2017

Currently, there are not many effective therapies available other than surgery, and that is not an option for many patients.

READ MORE